The clinical course and outcome of COVID-19 are highly variable, ranging from
asymptomatic infections to severe disease and death. Understanding the risk factors of …

The novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is
responsible for the current pandemic, coronavirus disease 2019 (COVID-19). While all …

Aim COVID-19 clinical presentation is heterogeneous, ranging from asymptomatic to severe
cases. While there are a number of early publications relating to risk factors for COVID-19 …

Abstract Background Severe Acute Respiratory Syndrome coronavirus-2 (SARS-CoV-2) has
challenged public health agencies globally. In order to effectively target government …

Since the first cases of the novel corona virus disease (COVID-19) were diagnosed in China,
outcomes associated with this infection in terms of total numbers of cases and deaths have …

SARS-CoV-2 infection leading to Coronavirus Disease 2019 (COVID-19) has caused more
than 762 million infections worldwide, with 10–30% of patients suffering from post-acute …

The pandemic of novel coronavirus disease (COVID‐19) is not yet close to being over, more
than 8 months after the first cases, but researchers are making great progress in fighting the …

The novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) causes major
challenges to the healthcare system. SARS-CoV-2 infection leads to millions of deaths …

Abstract Coronavirus disease 2019 (COVID‐19) has become a pandemic, but its reported
characteristics and outcomes vary greatly amongst studies. We determined pooled …

Background: Most respiratory viruses show pronounced seasonality, but for SARS-CoV-2,
this still needs to be documented. Methods: We examined the disease progression of COVID …